Cargando…
Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe
Glioblastoma multiforme is resistant to conventional anti-tumoral treatments due to its infiltrative nature and capability of relapse; therefore, research efforts focus on characterizing gliomagenesis and identifying molecular targets useful on therapy. New therapeutic strategies are being tested in...
Autores principales: | Cornago, M, Garcia-Alberich, C, Blasco-Angulo, N, Vall-llaura, N, Nager, M, Herreros, J, Comella, J X, Sanchis, D, Llovera, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237242/ https://www.ncbi.nlm.nih.gov/pubmed/25275596 http://dx.doi.org/10.1038/cddis.2014.412 |
Ejemplares similares
-
OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases
por: Ji, Wenbin, et al.
Publicado: (2016) -
Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
por: Filippi-Chiela, Eduardo C, et al.
Publicado: (2013) -
DNA damage checkpoint activation impairs chromatin homeostasis and promotes mitotic catastrophe during aging
por: Crane, Matthew M, et al.
Publicado: (2019) -
An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe
por: Rello-Varona, S, et al.
Publicado: (2010) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)